B. Bhanu Prasad Reddy*, Dr. D. Hepcy Kalarani, Dr. P. Venkatesh, Dr. R. Prema


Chronic obstructive pulmonary disease (COPD) results in high morbidity and mortality among patients both domestically and globally. Chronic bronchitis and emphysema are older terms used for different types of COPD. Chronic obstructive pulmonary disease is a highly prevalent disease characterized by non reversible airway obstruction. Well characterized symptoms such as exertional dyspnea and fatigue have a negative impact on patient’s quality of life and restrict physical activity in daily life. The impact of COPD symptoms on quality of life is often underestimated; for example, 36% of patients who describe their symptoms as being mild to moderate also admit to being to breathless to leave the house. Additionally, early morning and nighttime symptoms are a particular problem. Methods are available to allow clinicians to accurately assess COPD symptoms, including patient questionnaires. Integrated approaches to COPD management, particularly pulmonary rehabilitation, are effective strategies for addressing symptoms, improving exercise capacity and potentially also increasing physical activity. Inhaled bronchodilators continue to be the mainstay of drug therapy in COPD, where options can be tailored to meet patient’s needs with careful selection of the inhaled mediation and the device used for its delivery. Overall, an integrated approach to disease management should be considered for improving quality of life and subsequent patient outcomes in COPD.

Keywords: Chronic obstructive pulmonary disease, patients, physical activity levels, pulmonary rehabilitation.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    SEPTEMBER 2023 Issue has been successfully launched on 1 SEPTEMBER 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction